ORAL CIPROFLOXACIN COMPARED WITH CONVENTIONAL INTRAVENOUS TREATMENT FOR PSEUDOMONAS AERUGINOSA INFECTION IN ADULTS WITH CYSTIC FIBROSIS
- 31 December 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 329 (8527), 235-237
- https://doi.org/10.1016/s0140-6736(87)90062-6
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosisAntimicrobial Agents and Chemotherapy, 1986
- CIPROFLOXACIN IN CYSTIC FIBROSISThe Lancet, 1986
- RESISTANCE TO CIPROFLOXACINThe Lancet, 1985
- CIPROFLOXACIN-RESISTANT PSEUDOMONASThe Lancet, 1985
- CLINICAL RESISTANCE TO LONG-TERM ORAL CIPROFLOXACINThe Lancet, 1985
- Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.Thorax, 1984
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- ANTIMICROBIAL CHEMOTHERAPY IN CYSTIC FIBROSIS PATIENTSActa Paediatrica, 1982